(VIANEWS) – Sabre Corporation (SABR) shares experienced a sharp 17.26% gain over five sessions from EUR2.03 to EUR2.36 on Tuesday – this came after two consecutive days of losses and following an upward trend in previous sessions. Meanwhile, the NASDAQ index rose 0.25% after experiencing an initial downward trend in previous session; Sabre Corporation closed…
(VIANEWS) – FibroGen (NASDAQ: FGEN) experienced an unprecedented 30.98% surge over the past 21 sessions, rising from EUR1.98 on February 28th to EUR2.59 at 12:57 EST Tuesday at 12:57, marking five straight sessions of gains. Meanwhile, NASDAQ is also showing signs of life with its Index currently up 0.39% at EUR16,447.96; FibroGen’s last close price…
About Viking Therapeutics Viking Therapeutics is a clinical-stage biopharmaceutical company, focused on the creation of innovative treatments for metabolic and endocrine conditions. VK2809, their lead drug candidate, is a tissue and receptor subtype selective agonist of thyroid hormone receptor beta currently in Phase IIb clinical trials for treating nonalcoholic steatohepatitis and nonalcoholic fatty liver disease…
(VIANEWS) – The NYSE opens in less than hour and McCormick & Company‘s pre-market value is already 6.31% up. McCormick & Company’s last close was $69.94, 25.9% below its 52-week high of $94.39. The last session, NYSE ended with McCormick & Company (MKC) sliding 0.13% to $69.94. NYSE fell 0.19% to $18,077.15, after two consecutive…
(VIANEWS) – The NYSE opens in less than hour and AMETEK‘s pre-market value is already 4.43% up. AMETEK’s last close was $182.76, 0.02% above its 52-week high of $182.72. The last session, NYSE finished with AMETEK (AME) sliding 0.21% to $182.76. NYSE slid 0.19% to $18,077.15, after two successive sessions in a row of losses,…
(VIANEWS) – The NASDAQ opens in less than hour and Viking Therapeutics‘s pre-market value is already 14.54% up. Viking Therapeutics’s last close was $69.19, 30.4% under its 52-week high of $99.41. The last session, NASDAQ finished with Viking Therapeutics (VKTX) dropping 0.52% to $69.19. NASDAQ slid 0.27% to $16,384.47, following the last session’s downward trend…
(VIANEWS) – The NASDAQ opens in less than hour and TherapeuticsMD‘s pre-market value is already 4.8% up. TherapeuticsMD’s last close was $2.29, 51.48% under its 52-week high of $4.72. The last session, NASDAQ finished with TherapeuticsMD (TXMD) sliding 0% to $2.29. NASDAQ dropped 0.27% to $16,384.47, following the last session’s downward trend on what was…
(VIANEWS) – The NASDAQ opens in less than hour and iShares Core MSCI Total‘s pre-market value is already 5.47% down. The last session, NASDAQ finished with iShares Core MSCI Total (IXUS) falling 0.09% to $67.51. NASDAQ fell 0.27% to $16,384.47, following the last session’s downward trend on what was a somewhat negative trend trading session….
About Cronos Group Cronos Group Inc. is an industry-leading cannabinoid company, specializing in the cultivation, production and marketing of premium cannabis products in Canada, Israel and Germany. Their offerings include dried flower, pre-rolls, oils vaporizers edibles tinctures from their Spinach Lord Jones PEACE NATURALS brands as well as hemp tinctures. Established in 2012 and headquartered…
(VIANEWS) – Pacific Biosciences of California (NASDAQ: PACB) stock prices fell 34.72% over 21 sessions from EUR5.53 to EUR3.61, from February 29th to March 14th. This decline occurred even as the wider NASDAQ market, dropped only 0.27% to EUR16,384.47; its stock now trading 75.19% below its 52-week high of EUR14.55. About Pacific Biosciences of California…
